PubMed:28393239 / 800-1026 JSONTXT

{"project":"LitCoin-entities","denotations":[{"id":"12634","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"},{"id":"12635","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"},{"id":"12636","span":{"begin":146,"end":155},"obj":"GeneOrGeneProduct"},{"id":"12637","span":{"begin":194,"end":199},"obj":"OrganismTaxon"},{"id":"12638","span":{"begin":200,"end":209},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A14","pred":"db_id","subj":"12634","obj":"NCBIGene:6278"},{"id":"A15","pred":"db_id","subj":"12635","obj":"MESH:D010190"},{"id":"A16","pred":"db_id","subj":"12636","obj":"NCBIGene:6278"},{"id":"A17","pred":"db_id","subj":"12637","obj":"NCBITaxon:9606"},{"id":"A18","pred":"db_id","subj":"12638","obj":"NCBIGene:6278"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-entities-OrganismTaxon-PD","denotations":[{"id":"T1","span":{"begin":114,"end":122},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":194,"end":199},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"NCBItxid:36549"},{"id":"A2","pred":"db_id","subj":"T2","obj":"NCBItxid:9606"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":226},"obj":"Sentence"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T9","span":{"begin":45,"end":55},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":56,"end":62},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0004982"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0004992"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T24","span":{"begin":0,"end":9},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"},{"id":"T26","span":{"begin":63,"end":68},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":146,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":182,"end":186},"obj":"GeneOrGeneProduct"},{"id":"T29","span":{"begin":200,"end":209},"obj":"GeneOrGeneProduct"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T15","span":{"begin":0,"end":9},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":146,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":200,"end":209},"obj":"GeneOrGeneProduct"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T11","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"originalLabel","subj":"T11","obj":"D010190"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T10","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":146,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":200,"end":209},"obj":"GeneOrGeneProduct"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T6","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0009831"},{"id":"A7","pred":"mondo_id","subj":"T6","obj":"0005192"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T9","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"D010190"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":114,"end":122},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":194,"end":199},"obj":"OrganismTaxon"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T7","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A7","pred":"#label","subj":"T7","obj":"D010190"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T12","span":{"begin":200,"end":209},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":146,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"},{"id":"T58134","span":{"begin":45,"end":62},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T91775","span":{"begin":194,"end":199},"obj":"OrganismTaxon"},{"id":"T68297","span":{"begin":114,"end":122},"obj":"OrganismTaxon"}],"attributes":[{"id":"A7","pred":"#label","subj":"T58134","obj":"D010190"}],"text":"Knockdown and overexpression of Psoriasin in pancreatic cancer cells was performed using specifically constructed plasmids, which either had anti-Psoriasin ribozyme transgene or the full length human Psoriasin coding sequence."}